BEUDAMED
    FDA Adverse Event Malfunction Summary report: N

    BD PYXIS¿ MEDBANK TOWER

    MDR report key: 25229005 · Received May 20, 2026

    Report

    Report Number
    2016493-2026-30494
    Event Type
    Malfunction
    Date Received
    May 20, 2026
    Date of Event
    April 23, 2026
    Report Date
    April 27, 2026
    Manufacturer
    CAREFUSION 303, INC.
    Product Code
    BRY
    UDI-DI
    10885403517167
    PMA / PMN Number
    EXEMPT
    Product Problem
    Yes
    Report Source
    Manufacturer report
    Reporter Location
    OH, US
    Reporter Occupation
    OTHER HEALTH CARE PROFESSIONAL
    Health Professional
    Yes

    Narratives

    Additional Manufacturer Narrative · 0

    A REVIEW OF THE COMPLAINT HISTORY FOR SN (B)(6) WAS PERFORMED IN SALESFORCE WHICH DID NOT LOCATE SIMILAR COMPLAINT(S) WITH THE SAME FAILURE MODE FOR THIS SERIAL NUMBER. A REVIEW OF THE DEVICE HISTORY RECORD FOR SN (B)(6) WAS PERFORMED FROM THE DATE OF MANUFACTURE, 28-MAY-2025 AND CONFIRMED THAT THIS DEVICE WAS NOT PREVIOUSLY RETURNED FOR SERVICING AND THERE WERE NO PRODUCTION FAILURES WHICH CORRELATES TO THE CUSTOMER REPORTED ISSUE. UPON INVESTIGATION OF THE ACTUAL DEVICE USED IN THIS INCIDENT, IT WAS DETERMINED THAT THE USER WAS UNABLE TO ISSUE THE MEDICATIONS. A TECHNICAL SUPPORT SPECIALIST (TSS) CONFIRMED THAT CUBEX APPLICATION WAS UP AND RUNNING AND POPULATE BUTTONS HAD NO FAILURES. DURING A CONFERENCE CALL WITH THE FACILITY SUPERVISOR LOGGED IN AND ATTEMPTED TO ISSUE THE FOLLOWING ORDERED ITEMS FOR PATIENT ID BUT RECEIVED THE MESSAGE ISSUE AMOUNT CANNOT EXCEED THE STATION QOH FOR EACH MEDICATION. THE TSS ADVISED THE SUPERVISOR TO CYCLE COUNT THE AFFECTED MEDICATIONS, AFTER WHICH QOH DISCREPANCIES WERE CORRECTED AND THE ITEMS WERE SUCCESSFULLY ISSUED, AND ISSUED ITEMS THROUGH OVERRIDE AS REQUESTED. ADDITIONALLY, AN RX VERIFY OVERRIDE REQUEST FOR THE MEDICATION WAS WITNESSED AND CONFIRMED AS SUCCESSFULLY RECEIVED IN THE RX VERIFY LIST. THE CUSTOMER WAS ADVISED TO CYCLE COUNT REMAINING CABINET ITEMS AND TO CALL BACK IF FURTHER MISMATCHES WERE NOTED. THE CUSTOMER CONFIRMED ALL MEDICATIONS WERE ISSUED SUCCESSFULLY AND AUTHORIZED CASE CLOSURE. THE SYSTEM FUNCTIONED AS INTENDED AFTER THE TECHNICAL SUPPORT SPECIALIST GUIDED THE CUSTOMER TO RESOLVE THE ISSUE.

    Description of Event or Problem · 0

    IT WAS REPORTED THAT WHEN USING THE BD PYXIS¿ MEDBANK TOWER USER WAS UNABLE TO ISSUE MEDICATIONS, INCLUDING AMLODIPINE 5 MG, LOSARTAN 25 MG, ELIQUIS 5 MG, AND OXYCODONE/APAP 5-325 MG. THE CUSTOMER STATED THAT THIS MALFUNCTION OCCURRED WHILE DISPENSING THE MEDICATION. THERE WERE NO ADVERSE EVENTS OR INJURIES REPORTED BASED ON THIS EVENT.

    Devices

    Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
    67384 BD PYXIS¿ MEDBANK TOWER AUTOMATED DISPENSING CABINET BRY CAREFUSION 303, INC. 500004500000 10885403517167

    Patients

    Seq Age Sex Outcome Treatment
    1 NA Unknown